1162673-62-2 Usage
Uses
Used in Recreational Drug Industry:
Methoxyphenidine is used as a recreational drug for its hallucinogenic and sedative effects, which are similar to those of phencyclidine (PCP) and ketamine. However, it is important to note that the use of methoxyphenidine in this context is illegal in some countries without proper authorization, and its potential for abuse and addiction raises significant health and safety concerns.
Used in Research and Development:
Methoxyphenidine may also be used in the field of scientific research and development, particularly in the study of psychoactive substances, their effects on the human brain, and the development of potential treatments for various neurological and psychiatric disorders. Its use in this context is typically restricted to controlled laboratory settings and under the supervision of qualified professionals.
Check Digit Verification of cas no
The CAS Registry Mumber 1162673-62-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,6,2,6,7 and 3 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1162673-62:
(9*1)+(8*1)+(7*6)+(6*2)+(5*6)+(4*7)+(3*3)+(2*6)+(1*2)=152
152 % 10 = 2
So 1162673-62-2 is a valid CAS Registry Number.
1162673-62-2Relevant academic research and scientific papers
PREPARATION METHOD OF RIVASTIGMINE, ITS INTERMEDIATES AND PREPARATION METHOD OF THE INTERMEDIATES
-
Page/Page column 7, (2010/10/05)
The present invention provides N-methylethylcarbamino-3-[(S)-1-(methyl-[(S)-1-phenylethyl] amino) ethyl] phenyl ester represented by formula (II) and its preparation method. The present invention also provides (S)-1-(3-methoxyphenyl)-N-methyl-N-[(S)-1-phenylethyl] ethylamine and 3-[(S)-1-(methyl-[(S)-1-phenylethyl] amino) ethyl] phenol as intermediates of the compound represented by formula (II), and the use of the compound represented by formula (II) for preparing rivastigmine used for treating Alzheimer disease.
Novel convenient synthesis of rivastigmine
Hu, Meng,Zhang, Fu-Li,Xie, Mei-Hua
experimental part, p. 1527 - 1533 (2009/10/17)
A novel and convenient synthesis of rivastigmine has been reported. This procedure provides high yield and excellent enantiomeric excess (100% ee) starting from the diastereromerically pure (S)-1-(3-methoxyphenyl)-N-[(S)-1- phenylethyl] ethanamine. Copyright Taylor & Francis Group, LLC.
